NCT03036098 2026-03-06CheckMate901Bristol-Myers SquibbPhase 3 Active not recruiting1,314 enrolled 23 charts 1 FDA
NCT03390504 2026-02-02THORJanssen Research & Development, LLCPhase 3 Active not recruiting629 enrolled 32 charts 1 FDA
NCT02516241 2026-01-28Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerAstraZenecaPhase 3 Active not recruiting1,126 enrolled 52 charts